Consun Pharmaceutical Group Limited

SEHK:1681 株式レポート

時価総額:HK$4.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Consun Pharmaceutical Group マネジメント

マネジメント 基準チェック /34

Consun Pharmaceutical Group's CEO is Meng An, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is CN¥19.79M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 1.76% of the company’s shares, worth HK$79.48M. The average tenure of the management team and the board of directors is 3.6 years and 3.6 years respectively.

主要情報

Meng An

最高経営責任者

CN¥19.8m

報酬総額

CEO給与比率5.5%
CEO在任期間less than a year
CEOの所有権1.8%
経営陣の平均在職期間3.6yrs
取締役会の平均在任期間3.6yrs

経営陣の近況

Recent updates

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12
Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Jun 01
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

May 04
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Apr 28
Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Apr 07
Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26
Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17
Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19
Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29
How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08
Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18
Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

CEO報酬分析

Consun Pharmaceutical Group の収益と比較して、Meng An の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023CN¥20mCN¥1m

CN¥785m

Sep 30 2023n/an/a

CN¥759m

Jun 30 2023n/an/a

CN¥734m

Mar 31 2023n/an/a

CN¥708m

Dec 31 2022CN¥17mCN¥1m

CN¥683m

Sep 30 2022n/an/a

CN¥660m

Jun 30 2022n/an/a

CN¥636m

Mar 31 2022n/an/a

CN¥613m

Dec 31 2021CN¥14mCN¥670k

CN¥590m

報酬と市場: Meng's total compensation ($USD2.73M) is above average for companies of similar size in the Hong Kong market ($USD379.00K).

報酬と収益: Mengの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Meng An (53 yo)

less than a year

在職期間

CN¥19,793,000

報酬

Mr. Meng An serves as Executive Chairman of the Board at Consun Pharmaceutical Group Limited since July 9, 2021 and serves a sits Chief Executive Officer from January 17, 2024. Mr. An being the Chairman of...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Meng An
CEO & Executive Chairmanless than a yearCN¥19.79m1.76%
CN¥ 79.5m
Quan Zhu
Chief Scientist & Executive Director3.6yrsCN¥742.00kデータなし
Hanxing Xu
Assistant GM3.3yrsCN¥774.00kデータなし
Peicheng Fang
CFO & VP4.3yrsデータなしデータなし
Lei Zhou
Assistant President4.4yrsデータなしデータなし
Haien Gao
Board Secretary10.2yrsデータなしデータなし
Chi Ming Yau
Company Secretary11.3yrsデータなしデータなし
Guorong Guo
Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd3.6yrsデータなしデータなし
Lianhui Chen
Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd3.6yrsデータなしデータなし

3.6yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: 1681の経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Meng An
CEO & Executive Chairman3.3yrsCN¥19.79m1.76%
CN¥ 79.5m
Quan Zhu
Chief Scientist & Executive Director11.5yrsCN¥742.00kデータなし
Hanxing Xu
Assistant GM3.3yrsCN¥774.00kデータなし
Guorong Guo
Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd3.6yrsデータなしデータなし
Lianhui Chen
Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd3.6yrsデータなしデータなし
Zhongshi Feng
Independent Non-Executive Director10.5yrsCN¥200.00kデータなし
Yujun Chen
Independent Non Executive Director5.1yrsCN¥200.00kデータなし
Lihua Zhang
Non-Executive Director2.9yrsデータなしデータなし

3.6yrs

平均在職期間

49.5yo

平均年齢

経験豊富なボード: 1681の 取締役会経験豊富 であると考えられます ( 3.6年の平均在任期間)。